A total of 873 Equity Offering deals (pending and completed) were announced in the Global Pharmaceuticals sector, in the last twelve months resulting in a total deal value of over $65,317.1 million. In the LTM period, November 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $8,892.6 million, resulting in an average deal value of $108.4 million during that month. On the other hand, the month of March 2022 was the most prolific in terms of deal volume, recording a total of 96 deals, resulting in an average deal value of $65.2 million during that month.
Of the 873 deals, the deal secured between Pfizer Inc and Arvinas Inc, was the largest Equity Offering deal in the Global Pharmaceuticals sector, which was valued at $350.0 million and was completed on July 22, 2021. The second-largest deal was between Invus Group LLC; Polaris Partners LLC; Redmile Group LLC; Samsara BioCapital LLC and Scholar Rock Inc, while the third-largest deal was between Avoro Capital Advisors LLC; Invus LP; Janus Henderson Investors; Perceptive Advisors LLC; Pfizer Inc; Redmile Group LLC; Roivant Sciences Inc; Sphera Global Healthcare Master Fund and Amicus Therapeutics Inc; Immunovant Inc; Sema4 OpCo Inc. The Invus Group LLC; Polaris Partners LLC; Redmile Group LLC; Samsara BioCapital LLC-Scholar Rock Inc deal and the Avoro Capital Advisors LLC; Invus LP; Janus Henderson Investors; Perceptive Advisors LLC; Pfizer Inc; Redmile Group LLC; Roivant Sciences Inc; Sphera Global Healthcare Master Fund-Amicus Therapeutics Inc; Immunovant Inc; Sema4 OpCo Inc deal were valued at $205.0 million and $200.0 million, respectively. The fourth-largest deal was between Baker Bros Advisors LP; Bpifrance Participations SA; Braidwell; Fairmount Partners LP; RA Capital Management LP; Venrock Healthcare Capital Partners LP; Vivo Capital LLC-DBV Technologies SA valued at $193.8 million, whereas the deal between The Goldman Sachs Group Inc-Mithra Pharmaceuticals SA valued at $114.5 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $1,155.0 million and accounted for nearly 1.77% of the total deals (by value) announced during the last twelve months. By region, North America accounted for 59.54% of the total Equity Offering deals done globally, and recorded a total deal value of $39,041.9 million, which accounted for 71.54% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer